Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice
Open Access
- 9 July 2019
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 17 (1) , 1-13
Abstract
Chronic gastritis has been demonstrated to be a key cause of gastric cancer (GC), and control of gastric inflammation is regarded as an effective treatment for the clinical prevention of gastric carcinogenesis. However, there remains an unmet need to identify the dominant regulators of gastric oncogenesis-associated inflammation in vivo. The mouse model for the study of inflammation-associated GC was induced by Benzo[a]pyrene (BaP) intragastric administration in Bcl6b−/− and wildtype mice on a C57BL/6 background. 5-Aza-2′-deoxycytidine (5-Aza), the demethylation drug, was intraperitoneally injected to restore Bcl6b expression. Human GC tissue array was used to analyse patient survival based on BCL6B and CD3 protein expression. Bcl6b was gradually downregulated by its own promoter hypermethylation in parallel to an increasing inflammatory response during the progression of BaP-induced gastric carcinogenesis in mice. Moreover, knockout of Bcl6b dramatically worsened the severity of gastric cancer and aggravated the inflammatory response in the BaP-induced mice GC model. Re-activation of Bcl6b by 5-Aza impeded inflammatory amplification and BaP-induced GC development, prolonging survival time in wildtype mice, whereas no notable curative effect occurred in Bcl6b−/− mice with 5-Aza treatment. Finally, significant negative correlations were detected between the mRNA levels of BCL6B and inflammatory cytokines in human GC tissues; patients harbouring BCL6B-negetive and severe-inflammation GC tumours were found to exhibit the shortest survival time. Epigenetic inactivation of Bcl6b promotes gastric cancer through amplification of the gastric inflammatory response in vivo and offers a new approach for GC treatment and regenerative medicine.Keywords
Funding Information
- National Natural Science Foundation of China (81602148, 81872422, 81672871, 81602563, 81871977)
- Natural Science Foundation of Fujian Province (2015J01523)
- Xiamen Municipal Bureau of Science and Technology (3502Z20154025)
This publication has 48 references indexed in Scilit:
- Helicobacter pylori-induced gastric inflammation and gastric cancerCancer Letters, 2014
- The role of aspirin in cancer preventionNature Reviews Clinical Oncology, 2012
- BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesisBlood, 2012
- Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkersScandinavian Journal of Gastroenterology, 2012
- Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)Endoscopy, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- To selectivity and beyondNature Biotechnology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Binding of BAZF and Bc16 to STAT6-Binding DNA SequencesBiochemical and Biophysical Research Communications, 2001
- Benzo-a-Pyrene: Environmental Partitioning and Human ExposureToxicology and Industrial Health, 1991